ANTHEM BIOSCIENCES LTD Share Price & Technical Analysis

ANTHEM · ₹772.3 (+0.90%)

Healthcare / Biotechnology

AI Score 37 · Bearish

₹772.3

+0.90%

Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the con

Price chart

Seasonality

May has 1 positive and 0 negative years (last 2 years shown)

26% return in 2026, -11% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-8%19%0%14%1%26%
255%8%-8%-7%-11%2%-11%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 37/100

Bearish · Uptrend · Uptrend

Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial manufacturing of RNA-based therapies, antibody-drug conjugates, peptides and oligonucleotides, lipids, biologics and biotherapeutics, fermentation, biosynthesis and biotransformation, and flow chemistry. It also manufactures and sells complex specialized fermentation-based active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2; microbial and mammalian biosimilars; probiotics, such as bacillus species, lactobacillus species, bifidobacterium species, streptococcus species and saccharomyces boulardii; enzymes; peptides, including semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide; nutritional actives, vitamin analogues, and APIs. The company was incorporated in 2006 and is based in Bengaluru, India.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

₹448.84B

P/E ratio

93.46

52W high

₹873.5

52W low

₹579.2

Volume

3,14,251

Related stocks in Healthcare

Frequently asked questions

What is ANTHEM BIOSCIENCES LTD share price today?
ANTHEM BIOSCIENCES LTD (ANTHEM) last traded around ₹772.3 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does ANTHEM have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ANTHEM. Download the app for real-time alerts.
How can I analyze ANTHEM BIOSCIENCES LTD stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro